Report of Independent Registered Public
Accounting Firm

To the Board of Trustees and Shareholders of
Highland Funds I:

In planning and performing our audits of the
financial statements of Highland Long/Short Equity
Fund, Highland Long/Short Healthcare Fund, Highland
Merger Arbitrage Fund, Highland Opportunistic Credit
Fund, and Highland iBoxx Senior Loan Fund
(constituting Highland Funds I, hereafter
collectively referred to as the Funds) as of and for
the year ended June 30, 2019, in accordance with the
standards of the Public Company Accounting Oversight
Board (United States), we considered the Funds
internal control over financial reporting, including
controls over safeguarding securities, as a basis
for designing our auditing procedures for the
purpose of expressing our opinion on the financial
statements and to comply with the requirements of
Form N-CEN, but not for the purpose of expressing an
opinion on the effectiveness of the Funds internal
control over financial reporting.  Accordingly, we
do not express an opinion on the effectiveness of
the Funds; internal control over financial
reporting.

The management of the Funds are responsible for
establishing and maintaining effective internal
control over financial reporting.  In fulfilling
this responsibility, estimates and judgments by
management are required to assess the expected
benefits and related costs of controls.  A funds
internal control over financial reporting is a
process designed to provide reasonable assurance
regarding the reliability of financial reporting and
the preparation of financial statements for external
purposes in accordance with generally accepted
accounting principles.  A funds internal control
over financial reporting includes those policies and
procedures that (1) pertain to the maintenance of
records that, in reasonable detail, accurately and
fairly reflect the transactions and dispositions of
the assets of the fund; (2) provide reasonable
assurance that transactions are recorded as
necessary to permit preparation of financial
statements in accordance with generally accepted
accounting principles, and that receipts and
expenditures of the fund are being made only in
accordance with authorizations of management and
trustees of the fund; and (3)  provide reasonable
assurance regarding prevention or timely detection
of unauthorized acquisition, use or disposition of a
funds assets that could have a material effect on
the financial statements.

Because of its inherent limitations, internal
control over financial reporting may not prevent or
detect misstatements.  Also, projections of any
evaluation of effectiveness to future periods are
subject to the risk that controls may become
inadequate because of changes in conditions, or that
the degree of compliance with the policies or
procedures may deteriorate.

A deficiency in internal control over financial
reporting exists when the design or operation of a
control does not allow management or employees, in
the normal course of performing their assigned
functions, to prevent or detect misstatements on a
timely basis.  A material weakness is a deficiency,
or a combination of deficiencies, in internal
control over financial reporting, such that there is
a reasonable possibility that a material
misstatement of the Funds annual or interim
financial statements will not be prevented or
detected on a timely basis.

Our consideration of the Funds internal control over
financial reporting was for the limited purpose
described in the first paragraph and would not
necessarily disclose all deficiencies in internal
control over financial reporting that might be
material weaknesses under standards established by
the Public Company Accounting Oversight Board
(United States).  However, we noted no deficiencies
in the Funds internal control over financial
reporting and its operation, including controls over
safeguarding securities that we consider to be
material weaknesses as defined above as of June 30,
2019.

This report is intended solely for the information
and use of management and the Board of Trustees of
Highland Funds I and the Securities and Exchange
Commission and is not intended to be and should not
be used by anyone other than these specified
parties.


/s/ PricewaterhouseCoopers LLP
Dallas, Texas
August 30, 2019